Dengue Fever Fluid Management
For dengue fever, crystalloid solutions (isotonic saline or Ringer's lactate) should be the first-line fluid therapy, with judicious administration tailored to disease phase and severity—colloids may be considered only in children with severe dengue shock syndrome (pulse pressure <10 mmHg) who are unresponsive to crystalloids. 1
Initial Fluid Strategy
For Uncomplicated Dengue (No Warning Signs)
- Oral rehydration is preferred for patients without warning signs or shock
- Adequate hydration with oral fluids to maintain urine output
- Avoid NSAIDs and aspirin due to bleeding risk 2
For Dengue with Warning Signs or Shock
Start with crystalloid solutions:
- Administer 10-20 mL/kg boluses of isotonic crystalloid (0.9% saline or Ringer's lactate) over 5-10 minutes 3, 4
- Reassess after every fluid bolus for signs of fluid responsiveness and volume overload 3, 4
- Monitor for clinical indicators: capillary refill time, skin mottling, peripheral pulses, mental status, and urine output (target ≥0.5 mL/kg/hour in adults, ≥1 mL/kg/hour in children) 1
Critical Phase Management (Days 3-7)
This is when plasma leakage and shock typically occur 2. Fluid management is crucial but must be carefully titrated:
Crystalloid vs. Colloid Decision Algorithm
For moderate dengue shock (pulse pressure 10-20 mmHg):
- Continue crystalloid resuscitation
- Both crystalloid and colloid solutions show similar outcomes 1
- Crystalloids remain first-line due to lower cost and fewer adverse effects
For severe dengue shock syndrome (pulse pressure <10 mmHg):
- If crystalloid resuscitation fails after adequate volumes, consider colloid solutions 1
- Medium-molecular-weight colloids may provide benefit in children with severe shock 1
- However, prolonged colloid use (>4 hours continuous infusion) significantly increases risk of respiratory compromise (OR 8.84) and need for mechanical ventilation (OR 8.16) 5
Critical Pitfalls to Avoid
Fluid overload is a major concern:
- Excessive or rapid fluid resuscitation increases rates of mechanical ventilation and worsening oxygenation 3, 4
- Watch for crepitations/crackles, extended neck veins, third/fourth heart sounds indicating fluid overload 1
- Stop fluid resuscitation if no improvement in tissue perfusion occurs 1
Avoid:
- Hydroxyethyl starches and dextran (concerns for acute kidney injury and coagulation impairment) 6
- Prophylactic platelet transfusions (not indicated) 7
- Plasma transfusions (no proven benefit in dengue) 2
Vasopressor Support
If fluid-refractory shock persists despite liberal fluid resuscitation:
- Use epinephrine or norepinephrine as initial vasoactive agents 3, 4
- Dopamine may be considered if epinephrine/norepinephrine unavailable, but is less preferred 3, 4
- Minimize doses to reduce dose-dependent adverse effects 1
Monitoring Strategy
Frequent reassessment is essential:
- Clinical examination multiple times daily 1
- Serial hematocrit and lactate measurements 8
- Point-of-care ultrasound (POCUS) can detect early plasma leakage: gallbladder wall thickening, ascites, pleural effusions 8
- These ultrasound findings often precede clinical presentation of shock 8
Recovery Phase Considerations
Once the critical leakage phase passes (typically after day 7):
- Fluid "deresuscitation" becomes important 6
- Reduce or discontinue IV fluids as capillary integrity restores
- Continued aggressive fluids during recovery can lead to fluid overload
Evidence Quality Note
The most recent high-quality evidence 5 from 691 children across Southeast Asian hospitals demonstrates that prolonged colloid use is associated with worse respiratory outcomes despite reducing recurrent shock episodes. This reinforces that crystalloid-first strategies with judicious, time-limited colloid use (if needed) represent the safest approach. The 2025 AHA/AAP guidelines 3, 4 and 2026 apheresis guidelines 2 consistently support this conservative fluid strategy, emphasizing that adequacy of resuscitation matters more than fluid type in most cases.